about
Olfaction in eating disorders and abnormal eating behavior: a systematic reviewCognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A ReceptorsClinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matricesPotential role of olive oil phenolic compounds in the prevention of neurodegenerative diseasesThe influence of genetic and environmental factors among MDMA users in cognitive performanceClinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in HumansNo evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activationFood addiction in a Spanish sample of eating disorders: DSM-5 diagnostic subtype differentiation and validation data.Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies.Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index.Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and responseModerate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperamentMediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial.Immunomodulating activity of MDMA.Physiological and brain activity after a combined cognitive behavioral treatment plus video game therapy for emotional regulation in bulimia nervosa: a case report.Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity.Non-linear pharmacokinetics of MDMA ('ecstasy') in humansHPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans.Protective effect of homovanillyl alcohol on cardiovascular disease and total mortality: virgin olive oil, wine, and catechol-methylathion.Active transmembrane drug transport in microgravity: a validation study using an ABC transporter model.Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidityDetermination of free serotonin and its metabolite 5-HIAA in blood human samples with consideration to pre-analytical factors.Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study).Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.Modulation of Higher-Order Olfaction Components on Executive Functions in Humans.Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans.Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota.Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment OutcomeNeurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled TrialA Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in WomenDecision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?The NUTRAOLEOUM Study, a randomized controlled trial, for achieving nutritional added value for olive oilsTreatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker ratsAn increase in visceral fat is associated with a decrease in the taste and olfactory capacity.Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young Adults
P50
Q26781590-1FCD188B-1DEC-4E54-9CC1-9A45EE31A3FAQ27347603-CF721E5B-A2F5-404D-BD4B-584F4E94DE61Q28243881-244C774C-A5A4-44A0-9C46-722D7CF81963Q28259010-DCA0CF15-DE86-4505-AA0E-20DEA4C1477BQ28477994-2D86821C-4F71-41E5-BEA2-0737E4830EA1Q28484562-57128D99-7D87-4424-9381-3125D4512A43Q28533998-8092A610-D7E5-4B79-A2C8-24479D0E0C41Q28540131-81D61A4A-AF31-49A1-8654-4CF99700688DQ30843690-98BDB438-3483-4C16-B2D7-AF589FD5E02CQ33427045-4EB7BE73-9E19-425E-8CD3-D619B1CCF2B1Q33439214-60318B7D-2AFD-40E0-AF8F-5CF82620471EQ33594246-D1B3DE5A-35AB-48A5-8429-34804A2E0930Q33903933-14F66649-C396-4CE5-A18D-DF854FB51177Q34015624-0471E354-95DF-4A2B-A400-849C0097568FQ34043972-97578D2A-A9A1-44D0-88A7-3DFC743F4DC6Q34086085-0C580061-6F11-456E-BFAD-440A2D3AC2DAQ34140305-7ABA852B-3358-4F1F-8832-42F0F6352E08Q34395675-23B7E215-B9DB-4696-8FED-65E5569E90D4Q34507084-35C9A7DD-5732-48FA-B676-CD7E0BB165F8Q34591155-BD5177D5-E69A-4617-8B91-8E35C45CDCEEQ34681744-C3060BF6-ABCC-46B1-A6E7-B8F1FFDFB9B6Q34688384-EB51201E-DC6F-4197-B6FD-F3D7BCF7CAF0Q35087097-D1669323-0E01-4219-93FF-A00D21BCA777Q35143914-9638E466-595F-41E0-91F2-1606033AFCD8Q35148128-F21F31F2-0D19-4F08-824B-A79314302B4FQ35222716-CCA5A27D-D92E-496F-9091-1F58636D4C02Q35659485-3BB06CAB-E764-49A0-9A29-073081557C01Q35661148-76B3A1BC-A71D-4300-9552-F52604A3DDCFQ35666060-05151543-6693-4731-AB2E-45F9626CB714Q35768218-4227F83A-A546-49BF-9E69-2C7E4F6FFC7AQ35833842-3D1C2025-77BE-4659-A6FE-1EF81CC37B87Q35850797-421EDA56-FC49-4688-A664-AC1F5B9E12F8Q35893972-4A300089-DF80-4CCF-B6C9-D101A537D702Q35894277-BC44D905-1652-4E82-998F-A0D7F7ECE342Q35915760-679B49C8-143C-4647-A16E-C659DB9AADD7Q36150020-C4BAC024-1E78-4443-8AFA-BC5AC7BCA927Q36172079-4424FFD5-6EDC-4D3C-ACBA-0B13A97F17D6Q36175367-A4BE31DC-4E21-4C40-8B56-04B6525323F0Q36269792-18F7C527-F9CF-4ACC-ABEA-CEE7468F8556Q36290131-A04EB1DA-AB10-42FD-8379-D0F7D580261F
P50
description
researcher ORCID ID = 0000-0002-6765-1866
@en
wetenschapper
@nl
name
Rafael de la Torre
@ast
Rafael de la Torre
@en
Rafael de la Torre
@nl
type
label
Rafael de la Torre
@ast
Rafael de la Torre
@en
Rafael de la Torre
@nl
prefLabel
Rafael de la Torre
@ast
Rafael de la Torre
@en
Rafael de la Torre
@nl
P1006
P214
P244
P1006
P106
P1580
P21
P214
P244
P31
P496
0000-0002-6765-1866
P7859
lccn-n89225913